Delivery Order SPE2DB22D2103-SPE2DB25FR8SQ

Award Date 1/13/25
Potential Completion Date 2/4/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, with a ceiling value of $6,165.34. The contract has a period of performance through April 30, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a ceiling value of $5,586.06 and is a firm-fixed-price delivery order with a completion date of November 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,082.67 for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through February 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $12,330.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,165.34 firm fixed-price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a ceiling value of $6,165.34 and a completion date of January 24, 2025. It is a Firm Fixed Price Delivery Order contract type. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp is a $6,165.34 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) for the specialty medication BENLYSTA 200 MG/ML AUTOINJECTML. The contract has an ultimate completion date of April 9, 2025 and was awarded on March 19, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $6,165.34 and is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $2,793.03 firm fixed-price delivery order is for the supply of the pharmaceutical product BENLYSTA 200 MG/ML AUTOINJECTML. The contract has an ultimate completion date of December 5, 2024 and was awarded on November 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price of $6,165.34 and a completion date of April 28, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB25FR8SQ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,165.34 and a performance period ending on February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/14/25, 10:42 AM